Gohar Mushtaq
Overview
Explore the profile of Gohar Mushtaq including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
657
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rafique Q, Rehman A, Afghan M, Ahmad H, Zafar I, Fayyaz K, et al.
Comput Biol Med
. 2023 Jun;
163:107191.
PMID: 37354819
The COVID-19 pandemic has necessitated the development of reliable diagnostic methods for accurately detecting the novel coronavirus and its variants. Deep learning (DL) techniques have shown promising potential as screening...
2.
Saleh O, Albakri K, Altiti A, Abutair I, Shalan S, Mohd O, et al.
CNS Neurol Disord Drug Targets
. 2023 May;
23(6):731-745.
PMID: 37211844
Long non-coding RNAs (IncRNAs) are regulatory RNA transcripts that have recently been associated with the onset of many neurodegenerative illnesses, including Alzheimer's disease (AD). Several IncRNAs have been found to...
3.
Khalid A, Haseeb A, Mushtaq G, Kamal M
EXCLI J
. 2022 Dec;
21:1304-1305.
PMID: 36483913
No abstract available.
4.
Chen K, Shen Z, Wang G, Gu W, Zhao S, Lin Z, et al.
Front Bioeng Biotechnol
. 2022 Oct;
10:986233.
PMID: 36185462
CRISPR/Cas technology originated from the immune mechanism of archaea and bacteria and was awarded the Nobel Prize in Chemistry in 2020 for its success in gene editing. Molecular diagnostics is...
5.
Ghaith H, Gabra M, Nafady M, Elshawah H, Negida A, Mushtaq G, et al.
Curr Pharm Des
. 2021 Dec;
28(39):3194-3201.
PMID: 34895117
The current coronavirus disease (COVID-19) pandemic has affected millions of individuals worldwide. Despite extensive research efforts, few therapeutic options currently offer direct clinical benefits for COVID-19 patients. Despite the advances...
6.
Batool S, Nawaz M, Mushtaq G, Parvaiz F, Kamal M
Saudi J Biol Sci
. 2017 Sep;
24(6):1155-1161.
PMID: 28855807
In humans, purine synthesis pathway consists of multi-functional enzymes. Nucleotide metabolism enzymes are potential drug targets for treating cancer and autoimmune diseases. Glycinamide ribonucleotide transformylase (GART) is one of the...
7.
Riederer P, Korczyn A, Ali S, Bajenaru O, Choi M, Chopp M, et al.
J Neural Transm (Vienna)
. 2017 Aug;
124(11):1431-1454.
PMID: 28766040
The prevalence of both Alzheimer's disease (AD) and vascular dementia (VaD) is increasing with the aging of the population. Studies from the last several years have shown that people with...
8.
Ghaffar A, Batool S, Mushtaq G, Kamal M
Curr Comput Aided Drug Des
. 2017 Mar;
13(3):222-233.
PMID: 28294049
Background: Adenosine-Monophosphate-Activated protein kinase (AMPK) is a conserved kinase that plays an important role in maintaining the homeostasis of cells. AMPK activation has a positive impact on treatment of diseases...
9.
Ahmad K, Baig M, Mushtaq G, Kamal M, Greig N, Choi I
Curr Alzheimer Res
. 2017 Feb;
14(11):1190-1197.
PMID: 28164765
Background: Alzheimer's disease (AD) is the most common and well-studied neurodegenerative disease (ND). Biological pathways, pathophysiology and genetics of AD show commonalities with other NDs viz. Parkinson's disease (PD), Amyotrophic...
10.
Marya , Khan H, Mushtaq G, Kamal M, Ahmad I
Curr Drug Metab
. 2017 Jan;
18(2):402-403.
PMID: 28093995
Malaria remains one of the major public health problems worldwide and it is responsible for a large number of morbidity and mortality. Especially, in the third world countries, it is...